Literature DB >> 12045318

Use of case manager ratings and weekly urine toxicology tests among outpatients with dual diagnoses.

Richard K Ries1, Dennis G Dyck, Robert Short, Debra Srebnik, Mark Snowden, Katherine Anne Comtois.   

Abstract

Use of drugs and alcohol by 43 predominantly male outpatients who had severe mental illness and a comorbid substance use disorder were assessed weekly through the ratings of experienced dual disorder case managers and through blinded research urine toxicology tests. The percentage of weeks in which drugs or alcohol were used was calculated on the basis of one or both assessments. The case managers often missed drug use over the weekends, which was detected by the urine toxicology tests. Agreement between the two methods varied widely, even when the ratings were made by highly experienced case managers. These findings have implications for monitoring patients with dual diagnoses and provide insight into the accuracy of case manager ratings.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12045318     DOI: 10.1176/appi.ps.53.6.764

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  6 in total

1.  Evaluation of ethyl glucuronide immunoassay urinalysis in five alcohol-dependent outpatients.

Authors:  Michael G McDonell; Debra Srebnik; Frank Angelo; Andrea M Sugar; Donelle Howell; Christina Rainey; John Roll; Robert Short; Richard Ries
Journal:  Am J Addict       Date:  2011-07-18

2.  Accuracy of self-report, biological tests, collateral reports and clinician ratings in identifying substance use disorders among adults with schizophrenia.

Authors:  Sarah L Desmarais; Richard A Van Dorn; Brian G Sellers; M Scott Young; Marvin S Swartz
Journal:  Psychol Addict Behav       Date:  2012-12-31

3.  High Agreement Between Benchtop and Point-of-Care Dipcard Tests for Ethyl Glucuronide.

Authors:  Emily Leickly; Jordan Skalisky; Sterling McPherson; Michael F Orr; Michael G McDonell
Journal:  Ther Drug Monit       Date:  2017-08       Impact factor: 3.681

4.  Determining ethyl glucuronide cutoffs when detecting self-reported alcohol use in addiction treatment patients.

Authors:  Jessica M Lowe; Michael G McDonell; Emily Leickly; Frank A Angelo; Roger Vilardaga; Sterling McPherson; Debra Srebnik; John Roll; Richard K Ries
Journal:  Alcohol Clin Exp Res       Date:  2015-04-10       Impact factor: 3.455

5.  High levels of agreement between clinic-based ethyl glucuronide (EtG) immunoassays and laboratory-based mass spectrometry.

Authors:  Emily Leickly; Michael G McDonell; Roger Vilardaga; Frank A Angelo; Jessica M Lowe; Sterling McPherson; Debra Srebnik; John M Roll; Richard K Ries
Journal:  Am J Drug Alcohol Abuse       Date:  2015-02-19       Impact factor: 3.829

6.  A pilot study of the accuracy of onsite immunoassay urinalysis of illicit drug use in seriously mentally ill outpatients.

Authors:  Michael G McDonell; Frank Angelo; Andrea Sugar; Christina Rainey; Debra Srebnik; John Roll; Robert Short; Richard K Ries
Journal:  Am J Drug Alcohol Abuse       Date:  2011-01-11       Impact factor: 3.829

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.